Related Experiment Videos

CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice

A Signore1, A Annovazzi, E Procaccini

  • 1Nu.M.E.D. Group, Clinica Medica II, University La Sapienza, Rome, Italy. a.signore@caspur.it

Diabetologia
|February 3, 1998
PubMed

Insights

Alpha cells in pancreatic islets constitutively express CD95L, forming a protective shield around beta cells in mice. This finding offers new insights into the mechanisms of beta-cell destruction in diabetes research.

Area of Science:

  • Immunology
  • Endocrinology
  • Diabetes Pathogenesis

Background:

  • The non-obese diabetic (NOD) mouse model is crucial for studying insulin-dependent diabetes mellitus (Type 1 Diabetes).
  • Mechanisms of pancreatic beta-cell destruction in NOD mice remain incompletely understood.
  • The CD95/CD95L system is a potential mediator of beta-cell death.

Purpose of the Study:

  • To investigate the expression of CD95 and CD95L in pancreatic alpha and beta cells.
  • To explore the role of CD95L in protecting beta cells within the islets of Langerhans.

Main Methods:

  • Immunohistochemistry and immunofluorescence techniques were employed.
  • Expression analysis was performed in NOD, non-obese resistant (NOR), and Balb/c mice.
  • Specific focus on alpha and beta cells within pancreatic islets.

Main Results:

  • Alpha cells in the islets of Langerhans constitutively express CD95L.
  • This expression forms a natural shield-like structure around beta cells.
  • Differential expression patterns were observed across mouse models.

Conclusions:

  • Constitutive CD95L expression by alpha cells may play a protective role for beta cells.
  • This finding provides a novel perspective on beta-cell protection mechanisms in diabetes.
  • Further research is warranted to elucidate the full implications of the CD95/CD95L system in diabetes pathogenesis.

Related Concept Videos